4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-006495
Chief Scientific Officer gave up 27,258 shares (to pay taxes)
- Chief Scientific Officer acquired 60,925 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2025-03-01 | Option exercise | +50,000 | 281,995 | D | ||
| Monahan Joseph Chief Scientific Officer | 2025-03-01 | Option exercise | +10,925 | 292,920 | D | ||
| Monahan Joseph Chief Scientific Officer | 2025-03-01 | Shares withheld for taxes | −27,258 | $1.99 | $54,243 | 265,662 | D |
| Derivatives | |||||||
| Monahan Joseph Chief Scientific Officer | 2025-03-01 | Option exercise · Restricted Stock Units | −50,000 | 0 | D | ||
| Monahan Joseph Chief Scientific Officer | 2025-03-01 | Option exercise · Restricted Stock Units | −10,925 | 10,925 | D | ||
Loading xslF345X05/form4-03042025_040310.xml…